Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Gisselbrecht

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2018
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphoma: Standard of Care After the PETAL Study?Christian Gisselbrecht
Best Practice & Research. Clinical Haematology|March 14, 2012
PrefaceChristian Gisselbrecht
The Lancet. Oncology|July 25, 2016
Is nivolumab an option for Hodgkin's lymphoma?Christian Gisselbrecht
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Should we replace dexamethasone, cytarabine, and cisplatin for relapsed lymphoma?Christian Gisselbrecht
The Lancet. Oncology|November 19, 2013
Can we improve ABVD in Hodgkin's lymphoma?Christian Gisselbrecht
La Revue Du Praticien|June 18, 2002
[Monoclonal antibodies in the treatment of lymphoma]Nicolas Mounier, Christian Gisselbrecht
Current Opinion in Oncology|December 21, 2010
Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab eraNicolas Mounier, Christian Gisselbrecht
Best Practice & Research. Clinical Haematology|March 14, 2012
Relapses, treatments and new drugsNicolas Mounier, Christian Gisselbrecht
Current Opinion in Oncology|August 11, 2018
New perspectives in the therapeutic approach of peripheral T-cell lymphomaChristian Gisselbrecht, David Sibon
Seminars in Oncology|February 1, 2017
Improving Second-Line Therapy in Aggressive Non-Hodgkin's LymphomaChristian Gisselbrecht, Nicolas Mounier
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2018
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphoma: Standard of Care After the PETAL Study?Christian Gisselbrecht
Best Practice & Research. Clinical Haematology|March 14, 2012
PrefaceChristian Gisselbrecht
The Lancet. Oncology|July 25, 2016
Is nivolumab an option for Hodgkin's lymphoma?Christian Gisselbrecht
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Should we replace dexamethasone, cytarabine, and cisplatin for relapsed lymphoma?Christian Gisselbrecht
The Lancet. Oncology|November 19, 2013
Can we improve ABVD in Hodgkin's lymphoma?Christian Gisselbrecht
La Revue Du Praticien|June 18, 2002
[Monoclonal antibodies in the treatment of lymphoma]Nicolas Mounier, Christian Gisselbrecht
Current Opinion in Oncology|December 21, 2010
Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab eraNicolas Mounier, Christian Gisselbrecht
Best Practice & Research. Clinical Haematology|March 14, 2012
Relapses, treatments and new drugsNicolas Mounier, Christian Gisselbrecht
Current Opinion in Oncology|August 11, 2018
New perspectives in the therapeutic approach of peripheral T-cell lymphomaChristian Gisselbrecht, David Sibon
Seminars in Oncology|February 1, 2017
Improving Second-Line Therapy in Aggressive Non-Hodgkin's LymphomaChristian Gisselbrecht, Nicolas Mounier
Pageof 15